Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) has emerged as an acquired immune‐mediated demyelinating disorder of the central nervous system distinct from multiple sclerosis (MS). Here, MOG is linked to myeloid sarcoma.